Risk Of Developing Liver Cancer After HCV Treatment

Tuesday, October 23, 2012

Learning From the Patient Experience: Optimizing Treatment Outcomes During DAA Therapy for HCV

Learning From the Patient Experience: Optimizing Treatment Outcomes During DAA Therapy for HCV

Each month this blog provides readers with a link to new education-related information on current hepatitis C therapies being used today in clinical practice.

Recently Clinical Care Options (CCO) published a video webcast led by Ira M. Jacobson MD., discussing practical interventions to maximize patient adherence to protease inhibitor–based HCV treatment, including treatment outcomes, side effects and medication access.
 
The CME begins with a patient video followed by an interactive test and lastly a discussion. The"discussion" is beneficial for anyone considering therapy, and does not included the hassle of migrating through the test. All links are provided below.
 
Click here to begin the program.
 
**Although, like any site offering continuing medical education (CME), it requires a free quick registration.

Learning From the Patient Experience: Optimizing Treatment Outcomes During DAA Therapy for HCV

Release Date:
October 22, 2012
 
 
 

No comments:

Post a Comment